QBE Hong Kong Offers New Mental Health Support Coverage for Individual Personal Accident Insurance Products

QBE Hong Kong Offers New Mental Health Support Coverage for Individual Personal Accident Insurance Products

HONG KONG, CHINA – Media OutReach – September 8, 2020 – QBE Hong Kong today announced the launch of a new mental health support coverage, offering unique COVID-19 support to individuals and their families, with a view to assisting people facing mental health concerns due to the pandemic.


The mental health support coverage is a new feature and it will help to subsidise consultations with professional psychologists for those suffering from mental wellbeing concerns brought on by enforced Work-From-Home (WFH) arrangements during COVID-19.


The new coverage[1]is being launched in response to how COVID-19 has radically changed how we live, work and communicate amid movement restrictions and new financial pressures. While work from home (WFH) arrangements have become a common precautionary measure to protect the safety and wellbeing of employees, this change has seen new types of risks become more prominent, with long periods of working remotely potentially having an impact on individuals’ health and mental wellbeing.


“In today’s world, there is no shortage of uncertainties. With COVID-19 adding further pressure to the economy, it also reminds all of us what matters most: family, friends, health, safety and wellbeing,” said Lei Yu, CEO North Asia and Regional Distribution Head. “Emotional and mental wellbeing is important when it comes to maintaining a healthy and balanced life. At QBE, we are committed to giving people the confidence to achieve their ambition by protecting them from potential barriers which may hold them back. In the near future, we are looking at creating new products to address mental wellness which will better protect our customers and their families.”


In early August, QBE Hong Kong had also extended the digital capabilities of eClaims to both personal and business insurance products so as to provide uninterrupted customer claims experience during the pandemic. All claims can be submitted online, anytime anywhere. Customers can also choose bank transfer as a preferred payment method for easier and faster settlement without the hassle of manual processing.


To learn more about COVID-19 insurance advice, please visit 


[1] Coverage applicable only to Individual Personal Accident Protection Plus purchased via Manulife B2C Customer Portal (from 1 September 2020) and Individual Personal Accident purchased via selected bank partners (from 1 October 2020), underwritten by QBE Hong Kong.

About QBE Hong Kong

QBE has been serving Hong Kong for more than a century. Today, QBE Hong Kong operations include QBE Hongkong & Shanghai Insurance Limited, QBE General Insurance (Hong Kong) Limited, and QBE Mortgage Insurance (Asia) Limited. As a leading general insurer, QBE Hong Kong provides a comprehensive range of non-life insurance solutions for both business and personal customers. QBE Hong Kong operates through an extensive network of professional insurance agents and brokers and has an exclusive distribution partnership with Hang Seng Bank and Manulife. To learn more about QBE Hong Kong, please visit

QBE Hong Kong is part of the International Division of QBE Insurance Group Limited, one of the world’s top general insurance and reinsurance companies. Headquartered in Sydney, QBE is listed on the Australia Securities Exchange (ASX). To learn more about QBE Insurance Group, please visit

The New Philips TAJS50 Bluetooth Speaker Redefines The Shape of Sound

The New Philips TAJS50 Bluetooth Speaker Redefines The Shape of Sound

Georg Jensen inspiration combines with Philips expertise for a unique mobile speaker


 – 8 September 2020 – The new Philips TAJS50
Bluetooth speaker was designed together with Georg Jensen to be simple, yet
striking. The gleaming polished steel top plate contrasts beautifully with the
tactile Kvadrat wool-blend speaker fabric. Home, office, or dinner party — the
contrasting design always makes a beautiful impression. The soft but tough
Kvadrat speaker fabric also makes the speaker easy to grip when you pick it up.

Spectacular Sound from a Compact Speaker


Despite its compact size and light weight, the TAJS50 has a rated power
output of 30W, and delivers powerful but delightfully detailed music and
speech. The beautiful wool-blend premium speaker fabric, from high-end
manufacturer Kvadrat, is acoustically transparent, allowing every sound to flow
freely from the speaker into the room. You can easily pair your TAJS50 with an
identical Philips Georg Jensen speaker to enjoy your music in stereo.

20 Hours Play Time and 20m Range

The battery gives you 20 hours play time from a full charge, and the
wireless range is up to 20m. Charging the speaker takes 6 hours, via the
included USB-C cable. There’s a handy USB-A port on the speaker that lets you
use the speaker as a power bank to charge a smart device.

The Philips TAJS50 Bluetooth speaker is available for an MSRP of
SGD$289 at all authorized Philips Audio distributors in Singapore from
September 8, 2020.

Find out more about Philips TAJS50 Bluetooth speaker now.

About TP Vision

TP Vision Europe B.V. (‘TP Vision’) is registered in the Netherlands,
with its head office in Amsterdam. TP Vision is a wholly owned company of TPV
Technology Limited (‘TPV’), which is one of the world’s leading monitor and TV

TP Vision is a consumer electronics key player in TV and audio
entertainment. TP Vision concentrates on developing, manufacturing and
marketing Philips-branded TV sets (Europe, Russia, Middle East, South America,
India and selected countries in Asia-Pacific) and Philips-branded audio
products (Globally) under trademark license by Koninklijke Philips N.V. We
combine the strong Philips brand with our product development and design
expertise, operational excellence, and industry footprint of TPV. We believe in
creating products that offer a superior audio and visual experience for

FWD Insurance Acquires Minority Stake in IPP Financial Advisers

FWD Insurance Acquires Minority Stake in IPP Financial Advisers

– Media OutReach – 8 September 2020 – Leading financial advisory company IPP Financial Advisers (“IPPFA”) and FWD Insurance (“FWD”) today announced a
strategic partnership that will see FWD own a minority interest in IPPFA, enabling
IPPFA to further cement its position as a premier financial advisory firm in
Singapore, and the Asia-Pacific region. 

Tay Huai Eng, CEO of IPP Financial Advisers said, “We are extremely
pleased to welcome FWD as our strategic partner in IPP Financial Advisers. As a
major pan-Asian Insurer, FWD’s capital resources, expertise, and market
knowledge will further enhance our company’s growth and expansion in Singapore
and the region. It will also strengthen our professional staffing and
technology capabilities.”

strategic alliance will enable FWD to design attractive and competitive Life
Insurance products that comprehensively meet the evolving life insurance
financial needs of clients. This expansion complements IPPFA’s already
extensive range of financial products, financial planning services and
investments capabilities. IPPFA will retain its position as an open
architecture financial planning institution with complete access to a
comprehensive range of products from different insurers and fund houses.

Adrian Vincent,
General Manager of FWD Singapore’s Life Business
shared, “We’re delighted to be
partnering with IPP Financial Advisers. Their reputation as a premier
organisation dedicated to providing excellent wealth planning and management
for their clients aligns with FWD’s ambition to make financial security
accessible to everyone. We share a mutual commitment to continued growth in the
region and look forward to supporting them as they continue to lead the way in
the financial planning arena.”

partnership will create a positive impact on IPPFA clients. Traditional
processes will be digitalized through the integration of FWD’s technology
solutions, simplifying the process for IPPFA customers. Backed by FWD’s
extensive network across Asia, it will also bolster customer confidence in IPPFA’s
commitment and growth in the region. Together with FWD, IPPFA plans to
strengthen its position in Singapore by expanding on its financial services
business significantly.

in 1983, the IPP financial services organisation is the pioneer in
comprehensive financial planning services in Singapore. As an industry leader,
IPPFA has set the industry benchmark with its time-tested financial planning
models covering the areas of wealth protection, accumulation, management and

Social Enterprise Summit 2020 Theme “new normal‧collective power”

Social Enterprise Summit 2020 Theme “new normal‧collective power”

Free public registration to e-meet 70+ social innovators


HONG KONG, CHINA – Media OutReach – 7 September 2020 – The 13th Social
Enterprise Summit (“SES 2020”)
will be held from 19 to 21 November 2020 with
the chosen theme “new normal‧collective power”. The
flagship annual International Symposium to inspire and empower social
innovation, with 70+ top international and local speakers in 20 sessions, will
be opening up for free this year to a wider audience’s participation and
exchange to co-create our new normal.


SES 2020 Theme: “new
normal * collective power”

19-21. 11. 2020 Online

The turn of the
decade 2020 begins with a pandemic affecting people around the world, raising
attention to health and changing the way people work, study, commute or
socialise. Everyone in our society will require some shifts to come out of the
current situations. Collective efforts are needed to re-focus on fostering
mutually reinforcing solutions, continuous communication towards common agendas
and making swift decisions based on current data and measurement. This
International Symposium will examine the process through 4 thematic tracks:
Community Empowerment, Digital Social Innovation, Sustainability and Business
as well as Education Innovation.


This year, the grandiose
speakers line up comprises over 70 leaders and social entrepreneurs from USA,
Australia, the Philippines, Indonesia, Singapore, South Korea, Thailand,
Mainland China, Hong Kong etc locations.


Keynote Speakers:

(US), Co-Author of New Power,
Co-Founder and CEO of Purpose, and Mr Henry TIMMS (US), Co-Author of New Power, President and CEO of Lincoln
Center, will discuss what “New Power” means in today’s connected world and how
to harness this rise of new power to make changes for a better world.


Thematic Session: Overcoming Challenges 2.0: Rebuilding City Resilience

Mr Francis NGAI
(HK), Founder and CEO of Social Ventures Hong Kong; Mr David YEUNG (HK),
Founder and CEO of Green Monday; Dr LAU Ming-Wai (HK), Founder and Director of
MWYO and Chairman of Chinese Estates Holdings Limited, and Ms Vicky FUNG (HK),
Co-founder of Every Life Is A Song, will examine the current challenges we are
facing in Hong Kong and what collective actions can be taken to rebuild
resilience in our city.


Free Registration for Social Enterprise Summit 2020 begins
15 September 2020 (Wednesday), please visit the following link:






About Social Enterprise Summit

Social Enterprise
Summit (SES)
 is a cross-sector platform to inspire and empower social
innovation and social entrepreneurship. The flagship International Symposium
builds on the experiences of over 70 speakers from 15 locations to inspire,
innovate, connect and collaborate with delegates from the civic society,
businesses, government and academic sectors from Hong Kong, China; Asia Pacific
region and beyond to advance positive societal changes. Community engagement activities are held in eight different districts in
Hong Kong during the year to expand the participation and reach beyond the
conference rooms, applying knowledge, social entrepreneurship and innovative
mindsets to various day to day life settings.

Infinix Officially Launches the Fashion Conscious Zero 8 in Kenya

Infinix Officially Launches the Fashion Conscious Zero 8 in Kenya

 – 7 September 2020 – Infinix,
a global leader in consumer electronics market, has today launched the Zero 8
smartphone in the Kenyan market. The Zero 8 is the company’s flagship series
for 2020/21. Though targeting the high-end market, the Zero 8 will retail at a
relatively affordable price of KES 28,999 and will be covered by a guarantee
policy of up to 25 months. The warranty
will cover repairs on any purchased Zero 8 device that malfunctions after purchase
for free as a bonus aftersales value addition to Zero 8 consumers.

The stylish and fashion-focused Infinix
Zero 8 runs on Android v10 operating
system, with its key feature being the
presence of a Media Tek Helio G90 processor. This, combined with its128 GB ROM and 8 GB RAM, will enable consumers
experience improved speeds and overall device performance, including quick
upload and download times and an amazing experience with the apps, compared to
the Zero 6. The 90HZ Full HD Display and G90T processor also means enhanced
performance for the cameras, including the wide angle, ultra-wide angle and
rear cameras that will take photographic performance to a new level.

“Infinix is taking a
step to be more premium and able to compete and be the face of this new
direction as a fashion-conscious brand. This direction is very much in tandem
with our target customers, whose lifestyle can be described as image and
fashion-conscious and trendy, with a taste for high end gadgets”, said Mike
Zhang, Infinix Kenya Brand Manager.

The smartphone is
backed by a 4500 mAh battery which signifies fast charging and a longer life
(31 hours talk time and 26 hours stand-by time). The connectivity features in
the smartphone include WiFi, Bluetooth, GPS, Volte, and more. It is 4G, 3G and

Zero 8 is, no doubt, set to redefine the company’s image when thinking about
their devices. Another salient feature is the device’s cameras, both on the
front and at the back. On the front, for the first time ever, Infinix has
released a device with two selfie cameras (48 + 8MP), fitting them in a
punch-hole setup. At the back, there’s a 64-megapixel main sensor headlining
the quad-camera setup housed in the diamond-style bump.

Still on the design, Infinix Zero 8 is
equipped with a dual-punch hole cut-out for the selfie snapper, present at the
top left corner. This includes a 48MP primary lens and an 8MP wide-angle lens.
It has a 90Hz refresh rate and 180Hz touch sampling rate display. The device
also features a 64MP quad-camera setup, in a prism-shaped module. The handset
has a USB Type-C port for charging and data transfer. The Infinix Zero 8 has the futuristic
appearance which naturally blends with the diagonal design and colours used.

“Infinix will continue to play its key role in developing devices that meet
the market needs as well as technology of the day that endear users to the
future lifestyle aspirations”, added Zhang.

Smartphones have become a key aspect in everyday life, enabling many people
to run their businesses from the comforts of their seats and giving them access
to the outside world.

Other than the
flagship mobile phone, Infinix is also set to venture into a new product
category with the impending launch of Infinix TV, aimed at fulfilling smart
lifestyle living in accordance with modern trends. The TV will also be running
on the android smart TV system after Infinix received approval from Google. It will
enjoy full features and benefits that come with the system, including ability
to stream from favorite apps, play music and games and cast from any device.

About Infinix

Infinix Mobile is a Shenzhen-based
smartphone company founded in 2013 and a subsidiary of Transsion. The brand was
born after the French mobile manufacturer Sagem Wireless was acquired in 2011.
The company has Research and Development (R&D) centers sprawling between
France and Korea and designs its phones in France.

Infinix is committed to building
cutting-edge technology and fashionably designed dynamic mobile devices to
create globally-focused intelligent life experiences through a merging of fashion
+ technology.

With the brand spirit of challenging
the norms, Infinix smart devices are designed specifically for young people who
want to stand out, reach out and be in sync with the world.

Global Initiative Outlines a “One Health” Approach to Reforming Wildlife Trade Laws

Global Initiative Outlines a “One Health” Approach to Reforming Wildlife Trade Laws

HONG KONG , CHINA – Media OutReach – 7 September 2020 – The Global Initiative to End Wildlife Crime (EWC) today outlined an innovative “One Health” approach to reforming wildlife trade laws that the group said would help avoid future devastating wildlife-related pandemics.

Photograph by Paul Hilton / Earth Tree Images™. Further press materials, copyright information and captions can be downloaded here.

“No organisation on its own can address the multiple threats that could lead to the emergence of new wildlife-related diseases, or the spread of older diseases, with potential catastrophic consequences for economies, people and wildlife,” said EWC chair, John E Scanlon AO. “We must take a collaborative global approach to wildlife trade, one that brings together animal, human and environmental health — a “One Health” approach — and embed it into the international legal framework if we want give ourselves the best chance of averting future wildlife-related pandemics.”

In a briefing paper released today, EWC proposes specific amendments to the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) to include public health and animal health criteria into the Convention’s decision-making processes.

“The COVID-19 crisis has brought home just how vulnerable we all are as a result of our dysfunctional and destructive relationship with wildlife and the natural world,” said EWC Steering Group member, Will Travers, OBE, Co-founder and Executive President of Born Free Foundation. “Transformative changes are clearly needed, and CITES, the global wildlife trade regulator with its 183 member countries, existing structures and compliance mechanisms, has the critical mass to play a vitally important role.”

The most likely explanation for COVID-19 is that the virus was transmitted to humans from a reservoir host, a horseshoe bat, via another intermediate host species such as a pangolin.

“We know that past pandemics, such as Ebola, SARS and MERS, have been caused by wildlife-related zoonotic diseases and we now understand the conditions that make spillover from animals to humans more likely,” said Lisa Genasci, CEO of the ADM Capital Foundation (ADMCF).

Despite this, current wildlife trade laws do not take into account public or animal health considerations. Amending these laws to include public and animal health criteria is an objective of EWC and the briefing paper details specific changes that could be made to the CITES Convention.  

There is growing political will within countries to address the root causes behind COVID-19 and reduce the risk of future zoonotic disease outbreaks. “We are seeing that policymakers around the world are becoming increasingly concerned about the nexus between conservation and public health,” said Susan Lylis, Executive Vice President of ICCF, “and they are motivated to find solutions to prevent future pandemics”.

CITES currently regulates international trade in live wildlife and wildlife products to ensure that trade is legal and sustainable.  EWC proposes new legally binding provisions, including a new Appendix, or list of species, to regulate wildlife trade that poses a threat to public health or animal health. 

These provisions will only allow trade after certain findings are made, including that the proposed trade is reviewed by public and animal health authorities and is found to not pose a significant risk to human or animal health. Proposed trade that does not meet these requirements will be prohibited. 

“CITES is the only legally binding international framework that fits this critical need,” said Craig Hoover, Executive Vice President of the Association of Zoos and Aquariums and Special Advisor to EWC on CITES. “By adding a new Article and Appendix to the treaty that lays out specific requirements and restrictions on the capture, transport, and trade of wildlife species that pose a risk to public or animal health, we can leverage a globally recognized and enforceable agreement to avert future pandemics.”

According to the EWC paper, to prevent the next wildlife-related pandemic, we must expand efforts to end illegal wildlife trade; and where wildlife trade threatens human and animal health, stop such trade, close wildlife markets and stem consumption.

To achieve this, the world could move swiftly to amend CITES to include a broader health-related mandate and increase collaboration with WHO, OIE and FAO.

“The world, its wildlife, its people, and its economy may depend on it”, Scanlon said.

About the Global Initiative to End Wildlife Crime

End Wildlife Crime is an alliance of individuals and organisations that
support the need for international law reforms. Chaired by John Scanlon AO,
former Secretary General of CITES, EWC aims to encourage States to fill serious
gaps in international law by advocating for and offering technical support to
create a new global agreement on wildlife crime and amend existing
international wildlife trade laws to include public and animal health in
decision making.

We believe this can be achieved by:

a) Advocating for the adoption of a fourth protocol on wildlife crime
under the UN Convention on Transnational Organised Crime; and
b) amending the Convention on International Trade in Endangered Species (CITES)
to include public health and animal health criteria into the Convention’s
decision-making processes.


Hosted by ADM Capital Foundation
in Hong Kong, chaired by Scanlon, and with a Steering Group comprising the Born
Free Foundation, the Food and Land Use Coalition, the Global Environmental
Institute and the ICCF Group, EWC represents environmental, policy, business
and public health interests. The initiative also includes Special Advisors on
private sector engagement, building partnerships and CITES, as well as a
technical support group that includes renowned international lawyers and


Champions of the Global
Initiative to End Wildlife Crime:

Founding Champions: ADM Capital, Association of Zoos
and Aquariums
, TreadRight Foundation, Wildlife Justice
, World Travel and Tourism Council.

Champions: African Wildlife Foundation,
Protection Initiative
World Commission on Environmental Law
, Robert H. N. Ho Family Foundation,The Jane Goodhall Institute Global.



‘What is
the impact of the coronavirus pandemic? Global experts answer the big
, Financial Times interview, July 2020

Crucial Step Toward Preventing Wildlife-Related Pandemics
, Scientific
American, 15 June 2020

Global Initiative to End
Wildlife Crime website.

Delivery of COVID-19 vaccine: DHL study shows how public and private sector can partner for success

Delivery of COVID-19 vaccine: DHL study shows how public and private sector can partner for success

  • Global delivery of 10 billion doses of
    serum needs scaled-up medical supply chains
  • A framework is provided to tackle
    future health emergencies beyond COVID-19

BONN, GERMANY – Media OutReach – September 7, 2020 – With first emergency use authorizations for COVID-19 vaccines
expected to be effective in the last quarter of 2020, logistics providers are
challenged to rapidly establish medical supply chains to deliver more than ten
billion doses worldwide. DHL, working with McKinsey & Company as
analytics partner, has published a white paper on securing a stable supply
chain for vaccines and medical goods during COVID-19, and future health crises.


Currently, more than 250 vaccines across seven platforms are being
developed and trialed. As COVID-19 vaccines have leapfrogged development
phases, stringent temperature requirements (up to -80°C) are likely to be
imposed for certain vaccines to ensure that their efficacy is maintained during
transportation and warehousing. This poses novel logistics challenges to the
existing medical supply chain that conventionally distributes vaccines at ~2–8°C.


In the paper, DHL evaluates how the transport of vaccines as a highly
temperature-sensitive product can be managed effectively to combat the further
spread of the virus. The scope of this task is immense: To provide global
coverage of COVID-19 vaccines, up to ~200,000 pallet shipments and ~15 million
deliveries in cooling boxes as well as ~15,000 flights will be required across
the various supply chain set-ups.


“The COVID-19 crisis emerged with an
unprecedented breadth and impact. It required governments, businesses, and the
logistics industry alike to adapt quickly to new challenges. As a world leader
in logistics, we want to share our experience of operating during one of the
biggest health crises in recent history, in order to develop strategies in an ever-more
connected world”, explains Katja Busch, Chief Commercial Officer DHL. “To protect lives
against the pandemic, governments have moved towards a more active role in
medical supply chains. Over the past few months, we have demonstrated that
sufficient planning and appropriate partnerships within the supply chain can
play a key role as governments work to secure critical medical supplies during
health emergencies such as this.”


Future public health crisis management to include public-private

Since the outbreak of the pandemic, demand for
medical supplies has surged. For example, UNICEF sourced 100 times more face
masks and 2,000 times more medical gloves than in 2019. Bringing medical
supplies from their distant sources to the frontline has been one of the most
crucial activities in pandemic response management in the first phase of the
health emergency. For PPE specifically, inbound logistics were a major
challenge due to geographically concentrated production, limited airfreight
capacity and a lack of inbound quality checks. To ensure stable medical supply in a future
health crisis, a comprehensive setup of public health crisis strategies and
structures needs to be established by governments with partnerships from both
public and private sectors.


“From the onset, Asia was in the cockpit of the
supply race with millions of PPE and test kits shipped out of China and South Korea respectively,” added Leonora Lim, Head of Life Science and Healthcare, DHL
Customer Solutions and Innovation, Asia Pacific. “The delivery of vaccines
would be a completely different ball game however given the scale of
distribution and strict temperature requirements. A close partnership between
the public and private sectors would address the urgent need for a viable
medical supply chain that will preserve the integrity of these vaccines and
have them delivered to over 200 countries and territories in a timely fashion.” 


To kick-start the dialogue among the different actors and
improve pandemic resilience in medical supply logistics, DHL provides a
framework for the cooperation of logistics companies with authorities, politicians, NGOs
as well as the life sciences industry. The framework helps to establish
measures to ensure the most stable and safe supply chains possible. Besides an
emergency response plan, this includes a partnership network, strong physical
logistics infrastructure and IT-enabled supply chain transparency. Lastly, a
response unit with a clear mandate should be put in place to implement all
critical activities at short notice.


To read the
complete white paper, please click on the following link:


Note to editors:

As the leading logistics
provider for the life sciences and healthcare industry, DHL provides
forward-thinking, intelligent healthcare logistics through a holistic range of
patient-centric solutions. More than 9,000 specialists work across DHL’s
dedicated global network so that pharmaceutical, medical devices, clinical
trials and research organizations, wholesalers and distributors, as well as
hospitals and healthcare providers are connected across the value chain and
through digitalization, from clinical trials to point of care, and every step
in between.


The organization
provides high-quality, fully compliant logistics and supply chain services, and
champions innovative technologies that benefit customers and deliver better
care for patients. DHL’s portfolio for the healthcare industry includes 150+
pharmacists, 20+ clinical trials depots, 100+ certified stations, 160+
GDP-qualified warehouses, 15+ GMP-certified sites, 135+ medical express sites,
and a time-definite international express network covering 220 countries and

DHL – The logistics company for the world

DHL is the leading global brand in
the logistics industry. Our DHL divisions offer an unrivalled portfolio of
logistics services ranging from national and international parcel delivery,
e-commerce shipping and fulfillment solutions, international express, road, air
and ocean transport to industrial supply chain management. With about 380,000
employees in more than 220 countries and territories worldwide, DHL connects
people and businesses securely and reliably, enabling global sustainable trade
flows. With specialized solutions for growth markets and industries including
technology, life sciences and healthcare, engineering, manufacturing &
energy, auto-mobility and retail, DHL is decisively positioned as “The
logistics company for the world”.

DHL is part of Deutsche Post DHL
Group. The Group generated revenues of more than 63 billion euros in 2019. With
sustainable business practices and a commitment to society and the environment,
the Group makes a positive contribution to the world. Deutsche Post DHL Group aims
to achieve zero-emissions logistics by 2050.

The logistics company for the world.

LeddarTech to Address Autonomous Driving, LiDAR, and Perception Technologies at CIOE Annual Conference from September 9-11, 2020

LeddarTech to Address Autonomous Driving, LiDAR, and Perception Technologies at CIOE Annual Conference from September 9-11, 2020

HONG KONG, CHINA –  Media OutReach – September 7, 2020 – LeddarTech®, an industry leader in environmental sensing solutions for autonomous vehicles and advanced driver assistance systems from level 1 to level 5 will participate and present at the 22nd China International Optoelectronic Exposition (CIOE) from September 9-11. This live event, is being held at the Shenzhen World Exhibition Center and brings together 3,000 exhibitors welcoming over 80,000 industry professionals to learn, share, and engage in 60 concurrent forums, seminars, and activities.


During the Optoelectronic Application Forum, LeddarTech’s Horry Cheng, Strategic Account Manager for China, will present “Flash LiDAR and Environmental Raw Data Fusion Perception Solutions” during the  MEMS Seminar: LiDAR Technology and Application sub-expo which runs concurrently with the China International Opto Expo. This session will explore both the roadmap for LiDAR technology relating to AD and ADAS as well as examine environmental perception for safer and more reliable autonomous driving. LeddarTech will also participate in a Round Table discussing the growth of LiDAR companies both in China and around the world. “LeddarTech China is honored to be presenting at this long-standing event that brings together industry leaders and colleagues in optoelectronics to discuss the advancements made in environmental sensing solutions as they pertain to mobility and autonomous driving,” said Frantz Saintellemy, President and COO of LeddarTech.


Attend LeddarTech’s Presentation: 

  • Flash LiDAR and Environmental Raw Data Fusion Perception Solutions
  • Date: September 10, 2020
  • Time: 11.15 a.m. China Standard Time
  • Location: Shenzhen World Exhibition Center 2B, 2nd Floor, Hall 2

Attend the Round Table Presentation:

  • 国内外激光雷达企业思想激荡
  • Date: September 10, 2020
  • Time: 1.30 — 2.40 p.m. China Standard Time
  • Location: Shenzhen World Exhibition Center 2B, 2nd Floor, Hall 2

Attendance is open to all delegates.

About LeddarTech

LeddarTech is a leader in environmental sensing solutions for autonomous vehicles and advanced driver assistance systems. Founded in 2007, LeddarTech has evolved to become a comprehensive end-to-end environmental sensing company by enabling customers to solve critical sensing and perception challenges across the entire value chain of the automotive and mobility market segments with its LeddarVision™ sensor-fusion and perception platform. LeddarTech delivers a cost-effective, scalable, and versatile LiDAR development solution to Tier 1-2 automotive system integrators that enables them to develop automotive-grade solid-state LiDARs based on the foundation of the LeddarEngine™. LeddarTech has 14 generations of solid-state LiDARs based on the LeddarEngine platform operating 24/7 in harsh environments. This platform is actively deployed in autonomous shuttles, trucks, buses, delivery vehicles, smart cities/factories, and robotaxi applications. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 80 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities from level 1-level 5.

Additional information about LeddarTech is accessible and on LinkedIn, Twitter and Facebook.


Daniel Aitken, Vice-President, Global Corporate Marketing and Communications, LeddarTech Inc.

Tel.: + 1-418-653-9000 ext. 232


Clive Szeto (Situ Zhiheng), General Manager of LeddarTech Asia

Leddar, LeddarTech, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, VAYADrive, VayaVision, and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

Clip TV and coocaa cooperation live streaming breaks e-commerce record with 2000 in sales

Clip TV and coocaa cooperation live streaming breaks e-commerce record with 2000 in sales

 – 5 September
2020 – Clip TV and coocaa cooperated live
streaming in more than 10 popular Vietnamese media platforms witnessed new
record-high numbers on September 3, drew nearly 36.000 views and more than


That was the first time ever coocaa brand and Clip TV
cooperated for the launching event of their newest product: 40S3G TV. Customers
could purchase the product with 5000K value coupons along with lifetime
memberships at the live stream showed on September 3 at 20:00. Immediately, on
September 4, the first wave of sales of 2000 units was all sold out. Along with
that impressive deal, customers who buy the first 1000 units can get an extra
year of free which means 2+1=3 years of warranty.


With high-end quality and breathtaking price, 40S3G
TV was launched in more than 10 popular Vietnamese media platforms including VN
Facebook, Instagram, YouTube, Lazada, Clip TV app, Facebook pages of Đời sống,
Thính, Vietnamnet, GenK, 2Sao.


This first time ever cross-brand cooperation spells
a new chapter of TV watching experience and overturns the traditional habits of
family entertainment. Coocaa 40S3G latest smart TV provides you with all free
content from Clip TV, which enable all customers to watch any their favorite
show at any time with no advertisements placed in. Just as easy and smooth as
you want.


Now the second wave of flash sale at the best offer
of 3.999.000VND will launch on coocaa Lazada online flagship store at on September 9. Seize this unbelievable opportunity and
click in for the best treat!


coocaa is a registered trademark of the
market-leading TV manufacturer Skyworth. Also, even coocaa has just launched,
it already has 23 years Japan standard quality since their product was produced
by a Toshiba factory with a really high standard. coocaa joined Vietnamese
market at the end of 2018, selling 5 smart TV models’ on Lazada including
55S5G, 50S5G, 40S5G, 40S5C and 32S5C, and set many records for top best-selling
products on this e-commerce platform.

Uni-Bio Science Group Receives IND Approval for Uni-PTH Liquid Injection by the National Medical Products Administration

Uni-Bio Science Group Receives IND Approval for Uni-PTH Liquid Injection by the National Medical Products Administration

Accelerating the Progress of 2nd Generation Uni-PTH Launch


HONG KONG, CHINA – EQS Newswire – 4 September 2020 – A fully integrated biopharmaceutical company — Uni-Bio Science Group Limited (the “Company”, together with its subsidiaries, the “Group”; Stock code: 00690.HK) is pleased to announce that Uni-PTH (pre-filled injection pen) or “2nd Generation Uni-PTH” has been successfully approved by the National Medical Products Administration (“NMPA”) for clinical trial with the acceptance number of CXSL2000138. The approval allows the Company to begin conducting bridging clinical trials, which will accelerate the launch of 2nd Generation Uni-PTH, expected as soon as 2022.

Uni-PTH is the world’s only anabolic (bone growing) agent for osteoporosis and ostealgia treatment. Its treatment mechanism is quite different from products already existing in the market. Rather than inhibiting bone absorption, Uni-PTH has been shown to be effective in stimulating new bone formation on quiescent bone surface. By stimulating new bone formation, Uni-PTH can quickly improve bone quality and increase bone density within 6 months of treatment, therefore reducing fracture incidence and bone pain, especially helpful in treating patients with moderate-to-severe osteoporosis and ostealgia. Furthermore, 2nd Generation Uni-PTH improves upon the formulation of 1st Generation Uni-PTH in terms of patient convenience. On 5th May 2020, the Company announced a strategic collaboration with Swiss self-care giant Yposmed to develop 2nd Generation Uni-PTH alongside YpsoPen®, a state-of-the-art pen injector with unparalleled dosing accuracy and minimized injection pain. Together with YpsoPen®, 2nd Generation Uni-PTH is designed to provide safer long-term self-care solution for osteoporosis and ostealgia patients.  

Mr. Kingsley Leung, the Chairman of Uni-Bio Science Group, said, “The approval of clinical trial application was faster than we expected. Moreover, the NMPA has been very open to new clinical trial strategies, our proposed development strategy was accepted after preparing detailed data supporting our rationale. Overall, the outcome will greatly decrease the time and resources needed to bring our 2nd Generation Uni-PTH to market! The change in attitude of the NMPA’s review process is highly encouraging for the Group to focus its R&D in innovative drugs. Leveraging on our development and regulatory experience with Uni-PTH and Uni-GLP, we hope to kick start our next phase of pipeline development, most likely focused on next-generation best-in-class biologics.”

About Uni-PTH

Uni-PTH (Parathyroid hormone 1-34 analogue or rhPTH (1-34)) is an effective agent treating osteoporosis and ostealgia. It is a Class VII prescription new drug and is the world’s only anabolic (bone growing) agent. Uni-PTH has the potential to offer patients in China an affordable and effective treatment option for osteoporosis and ostealgia compared to current treatment options. Currently, the PRC osteoporosis market is expected to be worth RMB15.5 billion (approximately one fifth of the global osteoporosis market) and will continue to grow quickly largely due to increasing prevalence of osteoporosis among the female and elderly population, rising standards of living and increasing awareness and education in bone health. In clinical trials, Uni- PTH has been shown to be effective in stimulating new bone formation on quiescent bone surface, which is treatment mechanism rarely seen in the market filled with products to inhibit bone absorption. By stimulating bone formation, Uni-PTH has the potential to reduce fracture incidence by improving bone qualities and increasing bone density. Currently, the Company is developing two formulations; 1st Generation Uni-PTH is a lyophilized powder, currently in market approval registration, and 2nd Generation Uni-PTH is a pre-filled injection pen, currently conducting bridging studies. Both products are expected to launch within the next 24 months. As high-tech innovative drug, 1st Generation Uni-PTH (powder) was granted high-precision industrialization project by Beijing Zhongguancun Science Park Management Committee (“the Committee”) in 2018.

About Uni-Bio Science Group

Uni-Bio Science Group Limited is principally engaged in the research and development, manufacture and distribution of biopharmaceutical products. The research and development center is fully equipped with a complete system for the development of genetically-engineered products with a pilot plant test base which is in line with NMPA requirements. The Group has two GMP manufacturing bases in Beijing and Shenzhen. The Group also has a highly efficient commercialization platform and marketing network. The Group focuses on the development of novel treatments and innovative drugs addressing the therapeutic areas of endocrine as diabetes and osteoporosis, ophthalmology and dermatology. Please visit the official website of Uni-Bio Science Group for more information: /